358 results on '"Franczyk, Beata"'
Search Results
2. Influence of Metabolic Dysregulation in the Management of Depressive Disorder—Narrative Review
3. Anemia of Chronic Kidney Disease—A Narrative Review of Its Pathophysiology, Diagnosis, and Management
4. Broader Perspective on Atherosclerosis—Selected Risk Factors, Biomarkers, and Therapeutic Approach
5. SGLT2 Inhibitors in Kidney Diseases—A Narrative Review
6. miRNA biomarkers in renal disease
7. The Role of Selected lncRNAs in Lipid Metabolism and Cardiovascular Disease Risk.
8. The Role of Antioxidants in the Therapy of Cardiovascular Diseases—A Literature Review.
9. Diabetic Cardiomyopathy—From Basics through Diagnosis to Treatment
10. Do Implantable Cardioverter-Defibrillators Prevent Sudden Cardiac Death in End-Stage Renal Disease Patients on Dialysis?
11. Associations of Dietary and Lifestyle Components with Atrial Fibrillation
12. Primary Electrical Heart Disease—Principles of Pathophysiology and Genetics
13. The Role of Oxidative Stress in Hypertension: The Insight into Antihypertensive Properties of Vitamins A, C and E.
14. From Atherosclerotic Plaque to Myocardial Infarction—The Leading Cause of Coronary Artery Occlusion.
15. Exploring the Significance of Gut Microbiota in Diabetes Pathogenesis and Management—A Narrative Review.
16. Role of Uremic Toxins, Oxidative Stress, and Renal Fibrosis in Chronic Kidney Disease.
17. Selenium as a Modulator of Redox Reactions in the Prevention and Treatment of Cardiovascular Diseases.
18. Unveiling Selected Influences on Chronic Kidney Disease Development and Progression.
19. Mechanosensitive Cation Channel Piezo1 Is Involved in Renal Fibrosis Induction
20. The Role of Intestinal Microbiota and Diet as Modulating Factors in the Course of Alzheimer’s and Parkinson’s Diseases
21. Liquid Biopsy: A New Avenue for the Diagnosis of Kidney Disease: Diabetic Kidney Disease, Renal Cancer, and IgA Nephropathy
22. Hepatorenal Syndrome—Novel Insights into Diagnostics and Treatment
23. New Insights into Cardiovascular Diseases Treatment Based on Molecular Targets
24. Serum NGAL, KIM-1, IL-18, L-FABP: new biomarkers in the diagnostics of acute kidney injury (AKI) following invasive cardiology procedures
25. Unveiling Familial Hypercholesterolemia—Review, Cardiovascular Complications, Lipid-Lowering Treatment and Its Efficacy.
26. Novel Therapeutic Approaches in the Management of Chronic Kidney Disease
27. Molecular Processes Involved in the Shared Pathways between Cardiovascular Diseases and Diabetes
28. New Insights into the Nephroprotective Potential of Lercanidipine
29. Novel Insights into the Molecular Mechanisms of Atherosclerosis
30. Advances in Treatment of Dyslipidemia
31. The Role of miRNA in Renal Fibrosis Leading to Chronic Kidney Disease
32. Advances in the Pathogenesis and Treatment of Resistant Hypertension
33. Definition and Characteristics of Hypertension Associated with Chronic Kidney Disease: Epidemiological Data
34. Statins in Chronic Kidney Disease—Effects on Atherosclerosis and Cellular Senescence
35. New Insights into the Use of Liraglutide—Impact on Cardiovascular Risk and Microvascular Outcomes
36. The Impact of Aerobic Exercise on HDL Quantity and Quality: A Narrative Review
37. Chronic Kidney Disease as a Comorbidity in Heart Failure
38. Cardiotoxicity of Selected Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Renal Cell Carcinoma
39. Does the Composition of Gut Microbiota Affect Hypertension? Molecular Mechanisms Involved in Increasing Blood Pressure
40. The Role of Long Noncoding RNA (lncRNAs) Biomarkers in Renal Cell Carcinoma
41. New Insights into the Use of Empagliflozin—A Comprehensive Review
42. The Importance of SGLT-2 Inhibitors as Both the Prevention and the Treatment of Diabetic Cardiomyopathy
43. Management of Familial Hypercholesterolemia with Special Emphasis on Evinacumab
44. The Role of Inflammation and Oxidative Stress in Rheumatic Heart Disease
45. The Influence of Lifestyle and Treatment on Oxidative Stress and Inflammation in Diabetes
46. Structural and Functional Changes in Aging Kidneys
47. New Insights into Molecular Mechanisms of Chronic Kidney Disease
48. The occurrence of atrial fibrillation in dialysis patients and its association with left atrium volume before and after dialysis
49. Do HDL and LDL subfractions play a role in atherosclerosis in end-stage renal disease (ESRD) patients?
50. Cellular Mechanisms of Coronary Artery Spasm
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.